PACS Group CEO Jason Hulse Murray sells 82,613 shares
All three sales were effected under a Rule 10b5-1 plan adopted May 18, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PACS Group, Inc. Co-Founder, CEO & Chairman Jason Hulse Murray sold 13,696 shares on October 22, 2026, at a weighted average price of $47.5475 per share. On October 23, he sold 22,722 shares at a weighted average price of $48.2084 and 46,195 shares at a weighted average price of $48.7885.
All three sales were effected pursuant to a Rule 10b5-1 trading plan adopted on May 18, 2026. The weighted average prices reflected multiple transactions at prices ranging from $47.50 to $47.65, $47.50 to $48.495, and $48.50 to $49.105, respectively.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F3 | 22,722 | $48.2084 | $1.10M |
| Sale | Common Stock F1, F4 | 46,195 | $48.7885 | $2.25M |
| Sale | Common Stock F1, F2 | 13,696 | $47.5475 | $651K |
Footnotes (4)
- F1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026.
- F2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $47.50 to $47.65 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $47.50 to $48.495 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $48.50 to $49.105 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Reporting Person regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Were Jason Hulse Murray's PACS sales made under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.